Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

STROKE

Patent foramen ovale increases stroke risk in older people

Patent foramen ovale (PFO) is prevalent among young patients with cryptogenic stroke, and PFO closure reduces the risk of recurrent stroke in these individuals. A new study confirms that PFO is also frequent in patients with cryptogenic stroke aged >60 years, but the optimal management of such patients remains unresolved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saver, J. L., Mattle, H. P. & Thaler, D. Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review. Stroke 49, 1541–1548 (2018).

    Article  Google Scholar 

  2. Mazzucco, S., Li, L., Binney, L. & Rothwell, P. M., Oxford Vascular Study Phenotyped Cohort. Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis. Lancet Neurol. 17, 609–617 (2018).

    Article  Google Scholar 

  3. Overell, J. R., Bone, I. & Lees, K. R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55, 1172–1179 (2000).

    Article  CAS  Google Scholar 

  4. Handke, M., Harloff, A., Olschewski, M., Hetzel, A. & Geibel, A. Patent foramen ovale and cryptogenic stroke in older patients. N. Engl. J. Med. 357, 2262–2268 (2007).

    Article  CAS  Google Scholar 

  5. Alsheikh-Ali, A. A., Thaler, D. E. & Kent, D. M. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 40, 2349–2355 (2009).

    Article  Google Scholar 

  6. Tadayon, S. C., Gornbein, J. & Saver, J. L. How often are detected PFOs causally-related in patients with cryptogenic ischemic stroke: publication bias-adjusted estimates [abstract]. Eur. Stroke J. 3 (Suppl.), 312 (2018).

    Google Scholar 

  7. Sabatine, M. S. et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713–1722 (2017).

    Article  CAS  Google Scholar 

  8. Anderson, F. A. Jr et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch. Intern. Med. 151, 933–938 (1991).

    Article  Google Scholar 

  9. Mojadidi, M. K. et al. Sleep apnea in patients with and without a right-to-left shunt. J. Clin. Sleep Med. 11, 1299–1304 (2015).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heinrich P. Mattle.

Ethics declarations

Competing interests

H.P.M. was the principal neurology investigator of the PC Trial of patent foramen ovale (PFO) closure versus medical therapy for cryptogenic stroke. J.L.S. was the principal investigator of the RESPECT Trial of PFO closure versus medical therapy for cryptogenic stroke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mattle, H.P., Saver, J.L. Patent foramen ovale increases stroke risk in older people. Nat Rev Neurol 14, 573–574 (2018). https://doi.org/10.1038/s41582-018-0050-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-018-0050-7

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing